Adaptive Biotechnologies (ADPT) Net Margin (2018 - 2026)
Adaptive Biotechnologies (ADPT) posted Net Margin of 74.79% for Q1 2026, down 271.27% sequentially from 20.14% in Q4 2025, and down 1772.0% YoY from 4.47% in Q1 2025.
Adaptive Biotechnologies (ADPT) Net Margin (2018 - 2026) Analysis & Trends
Adaptive Biotechnologies has reported Net Margin for 9 years, with the latest figure at 74.79% in Q1 2026.
- Quarterly Net Margin fell 1772.0% year-over-year to 74.79% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 61.32% (up 1216.0% YoY) and the FY2025 annual result came in at 22.38%, up 6799.0% from the prior year.
- Net Margin slipped to 74.79% in Q1 2026 per ADPT's latest filing, from 20.14% in the prior quarter.
- Over five years, Net Margin peaked at 10.16% in Q3 2025 and troughed at 620.92% in Q2 2023.
- A 5-year average of 154.77% and a median of 107.08% in 2024 frame the typical range for Net Margin.
- The sharpest annual moves came in 2022 and 2023: Net Margin jumped 75763 bps in 2022, then slumped 46934 bps in 2023.
- Over 5 years, Net Margin stood at 70.44% in 2022, then plunged by 115 bps to 151.73% in 2023, then soared by 57 bps to 65.32% in 2024, then surged by 69 bps to 20.14% in 2025, then tumbled by 271 bps to 74.79% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 74.79%, 20.14%, and 10.16% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 14.65% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 13.89% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -8.89% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 18.47% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 5.52% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 27.82% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 17.86% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 22.67% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 8.02% |
| 10 | Adaptive Biotechnologies | 4.23 Bn | 3.89 Bn | 51.39 Mn | -22.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -22.65% |
| Mar 31, 2026 | -28.24% |
| Dec 31, 2025 | -18.94% |
| Sep 30, 2025 | 10.16% |
| Jun 30, 2025 | -43.47% |
| Mar 31, 2025 | -56.88% |
| Dec 31, 2024 | -71.04% |
| Sep 30, 2024 | -69.12% |
| Jun 30, 2024 | -107.08% |
| Mar 31, 2024 | -113.52% |
| Dec 31, 2023 | -151.73% |
| Sep 30, 2023 | -132.72% |
| Jun 30, 2023 | -620.92% |
| Mar 31, 2023 | -153.27% |
| Dec 31, 2022 | -72.77% |
| Sep 30, 2022 | -94.75% |
| Jun 30, 2022 | -119.29% |
| Mar 31, 2022 | -162.60% |
| Dec 31, 2021 | -161.76% |
| Sep 30, 2021 | -141.89% |